McKesson Corporation $MCK Shares Bought by Orion Porfolio Solutions LLC

Key Points

• Orion Portfolio Solutions LLC raised its stake in McKesson by 27.6% in Q3, buying an additional 4,892 shares to hold 22,629 shares valued at about $17.48 million.
• Several large institutions also increased or initiated positions—including Vanguard, Geode, AllianceBernstein, Arrowstreet and Norges Bank—leaving roughly 85.07% of McKesson stock held by hedge funds and other institutional investors.
• McKesson beat Q4 expectations with EPS of $9.34 (vs. $9.19 est.) and revenue of $106.16 billion (+11.4% YoY), set FY2026 EPS guidance of $38.80–$39.20, and declared a $0.82 quarterly dividend (0.4% yield).

Orion Porfolio Solutions LLC raised its position in McKesson Corporation (NYSE:MCK - Free Report) by 27.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,629 shares of the company's stock after purchasing an additional 4,892 shares during the period. Orion Porfolio Solutions LLC's holdings in McKesson were worth $17,482,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of MCK. Vanguard Group Inc. increased its holdings in McKesson by 2.0% in the second quarter. Vanguard Group Inc. now owns 12,072,090 shares of the company's stock valued at $8,846,186,000 after buying an additional 232,286 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of McKesson by 4.1% during the 2nd quarter. Geode Capital Management LLC now owns 2,820,724 shares of the company's stock worth $2,057,065,000 after acquiring an additional 112,224 shares in the last quarter. Alliancebernstein L.P. increased its holdings in shares of McKesson by 150.4% in the 2nd quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company's stock valued at $1,661,956,000 after acquiring an additional 1,362,386 shares during the last quarter. Norges Bank acquired a new stake in shares of McKesson during the 2nd quarter worth about $1,346,661,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in McKesson by 56.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company's stock worth $906,109,000 after purchasing an additional 446,060 shares during the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

McKesson Stock Performance

Shares of NYSE:MCK opened at $931.00 on Friday. McKesson Corporation has a one year low of $626.33 and a one year high of $999.00. The stock has a market capitalization of $114.04 billion, a price-to-earnings ratio of 26.78, a PEG ratio of 1.58 and a beta of 0.38. The company has a 50-day simple moving average of $880.72 and a 200-day simple moving average of $814.03.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm had revenue of $106.16 billion for the quarter, compared to analysts' expectations of $105.98 billion. During the same quarter in the previous year, the firm posted $8.03 EPS. The firm's revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson's dividend payout ratio (DPR) is currently 9.43%.

Insider Transactions at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michele Lau sold 2,725 shares of the company's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the transaction, the executive vice president owned 3,247 shares of the company's stock, valued at approximately $3,214,530. The trade was a 45.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,868 shares of company stock worth $3,743,820 over the last quarter. 0.08% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Weiss Ratings lowered shares of McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a research note on Thursday, February 5th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of McKesson in a research report on Wednesday, December 10th. Leerink Partners reissued an "outperform" rating and issued a $1,085.00 price target on shares of McKesson in a research report on Thursday. Barclays lifted their target price on McKesson from $960.00 to $1,050.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 18th. Finally, Mizuho upped their target price on McKesson from $880.00 to $885.00 and gave the company a "neutral" rating in a research report on Thursday, February 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $960.93.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.